Orexo: A transformative year
Research Note
2021-01-28
09:14
Redeye lowers somewhat the fair value per share of Orexo to SEK 59 (62). Although we expect revenues to stabilise, the new policy to have a positive impact, digital therapies to pick up and OX124 to show progress, investments will be needed. We would like to see more tangible signals about revenue growth.
GA
Gergana Almquist
Disclosures and disclaimers